Clinical Research

Predictive model uses 6 ultrasound features to differentiate between benign and malignant thyroid nodules
Once the model is further validated, it could help guide providers in determining how to manage thyroid nodules.
Early TAVR or SAVR in asymptomatic patients linked to improved survival, reduced costs
Researchers explored data from more than 24,000 AVR patients, presenting their findings at EuroPCR in Paris.
Work begins on first ATTR-CM study of its kind
ACT-EARLY is testing the hypothesis that treating asymptomatic carriers of a pathogenic TTR variant with the drug acoramidis could delay amyloidosis from developing.
Philips trial to test feasibility of reducing radiation during coronary interventions
The Philips Azurion interventional imaging system was recently updated with new ultralow dose technology that is said to reduce X-ray exposure by up to 50% during coronary procedures.
IVL delivers significant value for women, real-world data confirm
Researchers tracked data from nearly 400 women with complex CAD who underwent treatment with Shockwave Medical's intravascular lithotripsy technology prior to PCI.

Low doses of radiation still increase risk of leukemia, lymphoma and myeloma

A new study found cumulative radiation exposure of 16 mSv to red bone marrow can cause an increased rate of some hematological malignancies.

Following heart failure guidelines could save 1.2 million lives per year

Millions of heart failure patients who qualify for standard medical therapies do not receive treatment due to poor health literacy, limited access to care and medication costs.

AURORA trial results for Flurpiridaz F-18 PET vs. SPECT discussed by principal investigator Jamshid Maddahi, MD.

'This could be a paradigm shift': How PET with newly approved flurpiridaz compares to SPECT

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview.

Do cancer treatments increase a patient's risk of cardiovascular disease?

Older cancer survivors appear to face higher risks of stroke, heart attack and heart failure. Early screening and preventative measures can help.

Post-mastectomy radiation therapy can be safely shortened prior to breast reconstruction

New research suggests that treatment regimens can be nearly halved without increasing the risk of recurrence or complications further down the road.

Medicare data stethoscope healthcare trends graphs finance financials

Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.

Focal pulsed field ablation (PFA) is a safe, effective treatment option for premature ventricular contractions (PVC), according to new data published in Circulation: Arrhythmia and Electrophysiology.[1]

PFA ablation safe, effective for treating premature ventricular contractions

Early data suggest PVC ablation with PFA technology is associated with a high success rate and minimal complications.

Long-term survival after valve-in-valve TAVR similar with self-expanding, balloon-expandable valves

Severe prosthesis-patient mismatch was more common with balloon-expandable valves, but that difference did not appear to impact outcomes.

Clinical Research

Predictive model uses 6 ultrasound features to differentiate between benign and malignant thyroid nodules

Early TAVR or SAVR in asymptomatic patients linked to improved survival, reduced costs

Work begins on first ATTR-CM study of its kind

Philips trial to test feasibility of reducing radiation during coronary interventions

IVL delivers significant value for women, real-world data confirm